These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 21425267)

  • 1. Axonal damage in multiple sclerosis.
    Haines JD; Inglese M; Casaccia P
    Mt Sinai J Med; 2011; 78(2):231-43. PubMed ID: 21425267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic aspects of multiple sclerosis.
    Boppana S; Huang H; Ito K; Dhib-Jalbut S
    Mt Sinai J Med; 2011; 78(2):207-20. PubMed ID: 21425265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
    Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent
    Wood ET; Ercan E; Sati P; Cortese ICM; Ronen I; Reich DS
    Neuroimage Clin; 2017; 15():780-788. PubMed ID: 28702353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting oligodendrocyte protection and remyelination in multiple sclerosis.
    Zhang J; Kramer EG; Mahase S; Dutta DJ; Bonnamain V; Argaw AT; John GR
    Mt Sinai J Med; 2011; 78(2):244-57. PubMed ID: 21425268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of primary axonal damage in a viral model of multiple sclerosis.
    Das Sarma J; Kenyon LC; Hingley ST; Shindler KS
    J Neurosci; 2009 Aug; 29(33):10272-80. PubMed ID: 19692601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological indicators of the neurodegenerative phase of multiple sclerosis.
    Zaffaroni M
    Neurol Sci; 2003 Dec; 24 Suppl 5():S279-82. PubMed ID: 14652789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal and neuronal degeneration in myelin diseases.
    Ohno N; Ikenaka K
    Neurosci Res; 2019 Feb; 139():48-57. PubMed ID: 30179642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology.
    Lee JY; Biemond M; Petratos S
    Neurodegener Dis Manag; 2015 Dec; 5(6):527-48. PubMed ID: 26619755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegeneration in autoimmune CNS inflammation.
    Herz J; Zipp F; Siffrin V
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of axonal damage in inflammatory central nervous system diseases.
    Neumann H
    Curr Opin Neurol; 2003 Jun; 16(3):267-73. PubMed ID: 12858061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences.
    Bjartmar C; Trapp BD
    Curr Opin Neurol; 2001 Jun; 14(3):271-8. PubMed ID: 11371748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal loss in multiple sclerosis: causes and mechanisms.
    Criste G; Trapp B; Dutta R
    Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
    Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
    Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D; Pham-Dinh D; Reynolds R
    Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demyelination in multiple sclerosis.
    Lubetzki C; Stankoff B
    Handb Clin Neurol; 2014; 122():89-99. PubMed ID: 24507514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal Repair.
    Lemus HN; Warrington AE; Rodriguez M
    Neurol Clin; 2018 Feb; 36(1):1-11. PubMed ID: 29157392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuronal injury in multiple sclerosis].
    Correale J; Meli F; Ysrraelit C
    Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Axonal degeneration in the pathogenesis of multiple sclerosis].
    Mirowska D; Członkowska A
    Neurol Neurochir Pol; 2002; 36(4):777-89. PubMed ID: 12418141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.